NRXP icon

NRX Pharmaceuticals

30 hedge funds and large institutions have $1.86M invested in NRX Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$58K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$296K
2 +$21K
3 +$19K
4
Renaissance Technologies
Renaissance Technologies
New York
+$16.8K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$7.58K

Top Sellers

1 -$84.5K
2 -$40.9K
3 -$17.5K
4
TSS
Two Sigma Securities
New York
-$13.8K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$9.28K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$665K
2
$296K
3
$190K
4
$134K
5
$92K
6
$69K
7
$64.6K
8
$56.4K
9
$52.5K
10
$40.8K
11
$34.5K
12
$29.1K
13
$23K
14
$21.5K
15
$20.1K
16
$13.4K
17
$9.06K
18
$8.81K
19
$8.42K
20
$7.73K
21
$6.7K
22
$4.66K
23
$4.6K
24
$3.28K
25
$2.49K